膦甲酸钠

膦甲酸钠对尿毒症大鼠甲状旁腺激素及肾脏Ⅱa型钠-磷协同转运体的影响

Effect of PFA on PTH and expression of type ⅱ a sodium-dependent phosphate cotransporter in the kidneys of uremic rats

目的评估膦甲酸钠联合人工肝支持系统治疗重型乙型肝炎的临床价值。

Objective To estimate the clinical value of combination of PFA with ALSS in the treatment of SHB .

目的评价泛昔洛韦、膦甲酸钠及氧化苦参碱的体外抗HBV作用。

Objective To determine and compare the anti-HBV effect of famciclovir , foscarnet and oxymatrine in vitro .

结论：膦甲酸钠对乙型肝炎的DNA聚合酶有快速直接的抑制作用，用于治疗活动性肝硬变有较好疗效。

Conclusion : The phosphine formic acid sodium has fast and direct inhibition to get enzymes together on DNA of hte hepatitis B. Used for treating the activity cirrhosis and having better curative effect .

目的：研究膦甲酸钠（foscarnetsodium，PFA）预防及治疗肾移植术后巨细胞病毒（cytomegalovirus，CMV）感染的临床疗效。

OBJECTIVE : To observe the efficacy and safety of foscarnet sodium in treatment of patients with cytomegalovirus ( CMV ) after renal transplantation .

研究肾移植术后巨细胞病毒（CMV）感染的诊断及预防性使用膦甲酸钠（PFA）治疗的疗效与毒副作用。

To study the diagnosis of cytomegalovirus ( CMV ) infection after renal transplantation and the effects and side effects of preventive use of foscarnet ( PFA ) .

目的：评估膦甲酸钠（PFA）治疗肾移植巨细胞病毒抗原（CMV-PP65抗原）血症的临床疗效和不良反应。

AIM : To assess the clinical effects and adverse reactions of foscarnet sodium ( PFA ) in the treatment of cytomegalovirus ( CMV ) antigenemia after renal transplantation .

探讨Renagel和膦甲酸钠（PFA）抑制高磷致甲状旁腺增生和PTH分泌的作用；

To research the effects of the Renagel ? and Phosphonoformic acid ( PFA ) on preventing parathyroid hyperplasia and parathyroid hormone ( PTH ) secretion ;

结果：治疗结束时，膦甲酸钠治疗组HBeAg和HBVdna阴转率分别为421%和613%，显著高于对照组（53%和129%）；

Results : At the end of treatment , the negative conversion rates of HBeAg and HBV DNA in treatment group were 42.1 % and 61.3 % , respectively , which were significantly higher than that in control group ( HBeAg 5.3 % , HBV DNA 12.9 % ) .

目的：了解膦甲酸钠（PFA）与细胞凋亡蛋白酶激活因子-1（APAF-1）基因启动子的关系，为PFA的作用机制提供理论依据。

Objective : To investigate the relationship of phosphonoformate ( PFA ) and apoptotic protease - activating factor - 1 ( APAF - 1 ) gene and explain the molecular biological mechanisms of PFA in antivirus functions .

膦甲酸钠治疗乙型重型肝炎38例

Foscarnet sodium in treatment of 38 patients with severe hepatitis B

膦甲酸钠治疗巨细胞病毒感染的临床观察

Clinical effects of foscarnet in the treatment of cytomegalovirus infection

膦甲酸钠治疗肾移植患者巨细胞病毒抗原血症及护理

Effectiveness and nursing of foscarnet treatment in cytomegalovirus antigenemia after kidney transplantation

磷对慢性肾衰鼠甲状旁腺增生的独立作用和膦甲酸钠干预的研究

Independent Role of Phosphorus on Parathyroid Gland Hyperplasia in Chronic Renal Failure Rats

膦甲酸钠的不良反应主要是轻度的胃肠道反应。

The adverse reaction was only mild gastrointestinal reaction .

膦甲酸钠注射液与4种大输液的配伍稳定性考察

Study on the Compatible Stability of Foscarnet Sodium Injection with 4 Infusion Solutions

目的：观察膦甲酸钠治疗带状疱疹的临床疗效及安全性。

Objective To investigate the clinical effect and safety of foscarnet sodium in herpes zoster .

强有力的抗乙肝病毒治疗重新实施，核苷酸类似物结合膦甲酸钠注射液有效地改善了患者的临床状况。

Potent anti-HBV treatment with nucleoside analogues and foscarnet sodium injection effectively improved patient clinical condition .

膦甲酸钠联合干扰素治疗慢性乙型病毒性肝炎的临床疗效

The clinical efficacy of combination therapy of foscarnet sodium and interferon in treatment of chronic hepatitis B

膦甲酸钠在肾移植术后临床应用的初步研究

Preliminary study of the efficacy of foscarnet sodium in treatment of patients with cytomegalovirus infection after renal transplantation

膦甲酸钠治疗慢性乙型肝炎重度患者的临床观察

The therapeutic efficacy of foscarnet sodium in the treatment of patients with chronic hepatitis B of severe type

目的：探讨膦甲酸钠治疗慢性重型乙型肝炎的疗效。

Objective To investigate the effectiveness of foscarnet sodium in the treatment of patients with chronic severe hepatitis B.

膦甲酸钠对免疫致敏大鼠急性肝损伤模型的干预作用研究

Experimental Study on Value of Foscarnet Sodium in Acute Liver Injury Model of Rats Induced by BCG and LPS

膦甲酸钠联合胸腺肽-α1治疗重型肝炎的临床观察

Clinical observation of treatment of gravis hepatitis B with foscavir see foscarnet sodium and thymic peptide - α _1

目的：探讨膦甲酸钠对免疫诱导的大鼠急性肝损伤的干预作用。

Aims : To explore the value of Foscarnet sodium in acute liver injury model of rats induced by BCG .

目的观察膦甲酸钠治疗慢性乙型肝炎的疗效及毒副反应，并观察膦甲酸钠对不同基因型慢性乙肝患者的疗效。

Objective To investigate the effectiveness of foscamet sodium in the treatment of patients with various types of chronic hepatitis B.

结论膦甲酸钠可以安全有效地治疗乙型重型肝炎，明显降低病死率。

Conclusion Foscarnet sodium can safely and effectively treat patients with severe hepatitis B and decrease the fatality of severe hepatitis B.

膦甲酸钠治疗重度黄疸型乙型肝炎的研究

Jaundice ( 3 ) D shape . ( 2 ) C shape ; Effects of foscarnet sodium on severe icteric hepatitis B

结论膦甲酸钠注射液治疗重度慢性乙型病毒性肝炎有较好的疗效和安全性。

Conclusion Foscarnet sodium injection has a good effect on severe chronic hepatitis B patients and it is safe to use on them .

目的系统评价膦甲酸钠与更昔洛韦治疗艾滋病相关巨细胞病毒视网膜炎的疗效及安全性。

Objective To evaluate the effectiveness and safety of foscarnet and ganciclovir for cytomegalovirus retinitis associated with acquired immune deficiency syndrome ( AIDS ) .